Launch week! 🎉
I just kicked off Press Ready Science, a newsletter about what it really takes for researchers, clinicians, and academics to talk to journalists like pros.
https://t.co/hTv7BTjFGJ
#SciComm#AcademicTwitter#MedTwitter#PressReadyScience
Every Monday, I’ll share short, practical tips from my decade as a health & science journalist to help you shine in your next interview.
Because media attention should be a feature of research and academic work, not an afterthought.
New post’s up 👇
[https://t.co/pM0GdO5Cny]
How can a newsletter get you press ready?
It's a fair question.
Press Ready Science won’t replace your PR team — but it will help you make interviews less stressful and media attention a little less overwhelming. #SciComm#AcademicTwitter#MedTwitter
So, here's the deal:
Each week, I’ll share quick (5 min or less) tips to help experts sound as smart in the news as they are in the lab.
Follow along 👇
https://t.co/PhGUyLTti9
Launch week! 🎉
I just kicked off Press Ready Science, a newsletter about what it really takes for researchers, clinicians, and academics to talk to journalists like pros.
https://t.co/hTv7BTjFGJ
#SciComm#AcademicTwitter#MedTwitter#PressReadyScience
“Being press ready” sounds simple — but after a decade in health journalism, I’ve seen how hard it is to turn deep expertise into quotable, memorable soundbites.
It’s not about dumbing things down. It’s about connecting.
It's been a minute since I’ve been active here 👋
I’ve been busy on the other side of the notebook — still reporting, editing, and generally racing around the world of health journalism.
#SciComm#AcademicTwitter#MedTwitter
Lately I’ve been thinking about how stressful it can be for researchers and clinicians to talk to reporters (and how it doesn’t have to be).
So I started something new: Press Ready Science, a newsletter for experts who want to sound as smart in the news as they are in the lab.
I don’t get to write profiles often, but I love when I do — especially when their work is as interesting and important as @KekoaMDPhD’s. My latest for @medpagetoday 👇🏻
https://t.co/ReoleZn2Gr Read this if you want to know how a short-sighted, profit-based decision (hospital selling out anesthesia services to private equity) can absolutely tank hospital culture, quality of life, and patient care. This is happening everywhere.
"It opens up a whole lot of doors for ways to automate some of the more menial tasks and the documentation tasks that clinicians don't love to do." -- Ashwin Nayak, MD, on his study finding that #ChatGPT can write good clinical notes.
@MedReporterMike
https://t.co/9zIwE91zZI
But a closer look reveals a more complex story, according to @chimoose:
A tighter snapshot showed physician Twitter use increased every day over the past 4 days, and July 13 saw more physician tweets than the day Threads launched.
#MedTwitter#threadsvstwitter
Comparing June 14-July 13 periods this year and in 2022, the number of physicians posting on Twitter decreased by 13% (73,371 vs 63,957) and the number of physician posts decreased by 21% (3,420,696 vs 2,718,280), according data shared by @HealthQuant
https://t.co/DAjLnkmHNT
"If you're looking to do a thumbnail sketch, I think you could actually say that a bunch of the doctors that were actively spending their time on Twitter a year ago have been spending it on Threads this year," @chimoose
"What should infuriate people is that this is all public-sponsored research, right? So we're paying twice for it as taxpayers -- once when we invest in the research, because NIH grants are all funded by taxpayer dollars, and then we pay for it again when we buy it off the shelf."
"Our findings suggest that ADHD medication should be the preferred choice for individuals with BPD with ADHD symptoms and suicidal behavior." --Johannes Lieslehto, MD, PhD
#MedTwitter#psychtwitter#ADHD
https://t.co/jX3hzqxSFa